Veradermics

About Veradermics

Veradermics, Inc. is an aesthetics and dermatology-focused biopharmaceutical company dedicated to advancing first-in-class therapeutics for common, under-innovated dermatologic and aesthetic conditions. The company aims to address unmet patient needs, transform care, and deliver meaningful breakthroughs for widespread conditions.

Products & Services

VDPHL01:A potential first non-hormonal oral therapy for men and women with Pattern Hair Loss (PHL), currently under evaluation.

Therapies for Androgenetic Alopecia:Innovative treatments targeting hair loss due to androgenetic alopecia.

Therapies for Common Warts:Novel therapies aimed at treating common warts, a widespread condition.

Therapies for Molluscum Contagiosum:Treatments under development for molluscum contagiosum, addressing patient needs.

Therapies for Alopecia Areata:Innovative solutions for alopecia areata, a condition causing hair loss.

Therapies for Atopic Dermatitis:Therapeutics targeting atopic dermatitis to improve patient outcomes.

Specialties

First-in-class therapeutics Aesthetics and dermatology Treatment of under-innovated conditions Novel therapies for hair loss and skin conditions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: IPO T: - FT: IPO	A: 294800000 MR: - FA: approximately $294.8 million FAN: 294800000	D: 2026-02-05 FD: 2026-02-05	-
2	RT: Initial Public Offering T: - FT: Initial Public Offering	A: 256300000 MR: - FA: approximately $256.3 million FAN: 256300000	D: 2026-02-03 FD: 2026-02-03	4 investors
3	RT: Series C T: - FT: Series C	A: 150000000 MR: - FA: $150 million FAN: 150000000	D: 2025-10-16 FD: 2025-10-16	11 investors
4	RT: Series B T: - FT: Series B	A: 75000000 MR: - FA: $75 million FAN: 75000000	D: 2024-12-11 FD: 2024-12-11	8 investors

IPO Latest

2026-02-05

$294.8M

Initial Public Offering 2026-02-03

$256.3M

Series C 2025-10-16

$150.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Veradermics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised